Having an option like semaglutide, which resulted in a mean 16.1% reduction in BMI in adolescents with obesity over 68 weeks in the STEP TEENS trial, should be extremely encouraging to providers who treat adolescents with obesity
Both Foundayo and Mounjaro most commonly cause gastrointestinal side effects, including nausea, diarrhea, vomiting, constipation, indigestion, decreased appetite, and abdominal discomfort
Although Ozempic is primarily FDA-approved for glycemic control in type 2 diabetes (T2D), its active ingredient, semaglutide, has a pleiotropic effect across multiple organ systems, including the cardiovascular and renal systems
When administered by a qualified medical professional, they carry minimal risk
Oral health assessment of a group of children with autism disorder